Growth hormone response to L-dopa in the thinned obese. 1982

L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell

The response of plasma growth hormone (GH) to 0.5 g L-dopa was studied in 17 obese nondiabetic subjects and in 6 normal-weight subjects, aged 16 to 46 yr. The test was repeated after the obese subjects were thinned 12 to 50 kg, either with a hypocaloric diet or by a jejunoileal shunt. All the obese subjects had a blunted response to L-dopa stimulation. Nine of the thinned obese continued to exhibit the same blunted GH response, while the other eight responded with a significant GH rise after L-dopa stimulation, although the increase was smaller than that in the controls. No correlation between the initial or final weight or the extent of weight loss and the response to L-dopa was observed. It is assumed that a hypothalamic underresponsiveness is responsible for the blunted response in the obese subjects and its persistence in some of the thinned obese.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
March 1972, The Journal of clinical endocrinology and metabolism,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
March 1974, Metabolism: clinical and experimental,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
March 1978, Metabolism: clinical and experimental,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
January 1976, Acta diabetologica latina,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
January 1977, Annales d'endocrinologie,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
July 1975, International journal of clinical pharmacology and biopharmacy,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
January 1983, Experimental and clinical endocrinology,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
January 1994, Anxiety,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
June 1985, Journal of autism and developmental disorders,
L Laurian, and Z Oberman, and E Hoerer, and T Wiznitzer, and A Harell
December 1990, Journal of autism and developmental disorders,
Copied contents to your clipboard!